Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 26 entries
Sorted by: Best Match Show Resources per page
Vitamin d and cardiovascular disease.

Current treatment options in cardiovascular medicine

Danik JS, Manson JE.
PMID: 22689009
Curr Treat Options Cardiovasc Med. 2012 Aug;14(4):414-24. doi: 10.1007/s11936-012-0183-8.

OPINION STATEMENT: Vitamin D has received widespread attention for its potential role in preventing cardiovascular disease (CVD) and type 2 diabetes mellitus. Several epidemiological studies have suggested that individuals with low blood levels of vitamin D have increased risks...

Cite
Danik JS, Manson JE. Vitamin d and cardiovascular disease. Curr Treat Options Cardiovasc Med. 2012;14(4):414-24doi: 10.1007/s11936-012-0183-8.
Danik, J. S., & Manson, J. E. (2012). Vitamin d and cardiovascular disease. Current treatment options in cardiovascular medicine, 14(4), 414-24. https://doi.org/10.1007/s11936-012-0183-8
Danik, Jacqueline S, and Manson, Joann E. "Vitamin d and cardiovascular disease." Current treatment options in cardiovascular medicine vol. 14,4 (2012): 414-24. doi: https://doi.org/10.1007/s11936-012-0183-8
Danik JS, Manson JE. Vitamin d and cardiovascular disease. Curr Treat Options Cardiovasc Med. 2012 Aug;14(4):414-24. doi: 10.1007/s11936-012-0183-8. PMID: 22689009; PMCID: PMC3449318.
Copy Download .nbib Format: NLM
Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses.

JBMR plus

Sluyter JD, Manson JE, Scragg R.
PMID: 33553987
JBMR Plus. 2020 Nov 04;5(1):e10420. doi: 10.1002/jbm4.10420. eCollection 2021 Jan.

The relationship between vitamin D status or supplementation and cancer outcomes has been examined in several meta-analyses. To address remaining knowledge gaps, we conducted a systematic overview and critical appraisal of pertinent meta-analyses. For meta-analyses of trials, we assessed...

Cite
Sluyter JD, Manson JE, Scragg R. Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses. JBMR Plus. 2020;5(1):e10420doi: 10.1002/jbm4.10420.
Sluyter, J. D., Manson, J. E., & Scragg, R. (2021). Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses. JBMR plus, 5(1), e10420. https://doi.org/10.1002/jbm4.10420
Sluyter, John D, et al. "Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses." JBMR plus vol. 5,1 (2021): e10420. doi: https://doi.org/10.1002/jbm4.10420
Sluyter JD, Manson JE, Scragg R. Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses. JBMR Plus. 2020 Nov 04;5(1):e10420. doi: 10.1002/jbm4.10420. eCollection 2021 Jan. PMID: 33553987; PMCID: PMC7839823.
Copy Download .nbib Format: NLM
Prolactin and Risk of Epithelial Ovarian Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.
PMID: 34244157
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08.

BACKGROUND: Prolactin is synthesized in the ovaries and may play a role in ovarian cancer etiology. One prior prospective study observed a suggestive positive association between prolactin levels and risk of ovarian cancer.METHODS: We conducted a pooled case-control study...

Cite
Hathaway CA, Rice MS, Townsend MK, et al. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1652-1659doi: 10.1158/1055-9965.EPI-21-0139.
Hathaway, C. A., Rice, M. S., Townsend, M. K., Hankinson, S. E., Arslan, A. A., Buring, J. E., Hallmans, G., Idahl, A., Kubzansky, L. D., Lee, I. M., Lundin, E. A., Sluss, P. M., Zeleniuch-Jacquotte, A., & Tworoger, S. S. (2021). Prolactin and Risk of Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1652-1659. https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway, Cassandra A, et al. "Prolactin and Risk of Epithelial Ovarian Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1652-1659. doi: https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08. PMID: 34244157; PMCID: PMC8419083.
Copy Download .nbib Format: NLM
Sexual and reproductive health information: Disparities across sexual orientation groups in two cohorts of U.S. women.

Sexuality research & social policy : journal of NSRC : SR & SP

Tabaac AR, Haneuse S, Johns M, Tan ASL, Austin SB, Potter J, Lindberg L, Charlton BM.
PMID: 34484460
Sex Res Social Policy. 2021 Sep;18(3):612-620. doi: 10.1007/s13178-020-00485-3. Epub 2020 Jul 22.

INTRODUCTION: Limited research exists about how receiving/seeking sexual and reproductive health (SRH) information differs by sexual orientation. Our goal was to identify how sources and topics of SRH information differed by sexual orientation during adolescence in a sample of...

Cite
Tabaac AR, Haneuse S, Johns M, et al. Sexual and reproductive health information: Disparities across sexual orientation groups in two cohorts of U.S. women. Sex Res Social Policy. 2020;18(3):612-620doi: 10.1007/s13178-020-00485-3.
Tabaac, A. R., Haneuse, S., Johns, M., Tan, A. S. L., Austin, S. B., Potter, J., Lindberg, L., & Charlton, B. M. (2021). Sexual and reproductive health information: Disparities across sexual orientation groups in two cohorts of U.S. women. Sexuality research & social policy : journal of NSRC : SR & SP, 18(3), 612-620. https://doi.org/10.1007/s13178-020-00485-3
Tabaac, Ariella R, et al. "Sexual and reproductive health information: Disparities across sexual orientation groups in two cohorts of U.S. women." Sexuality research & social policy : journal of NSRC : SR & SP vol. 18,3 (2021): 612-620. doi: https://doi.org/10.1007/s13178-020-00485-3
Tabaac AR, Haneuse S, Johns M, Tan ASL, Austin SB, Potter J, Lindberg L, Charlton BM. Sexual and reproductive health information: Disparities across sexual orientation groups in two cohorts of U.S. women. Sex Res Social Policy. 2021 Sep;18(3):612-620. doi: 10.1007/s13178-020-00485-3. Epub 2020 Jul 22. PMID: 34484460; PMCID: PMC8414943.
Copy Download .nbib Format: NLM
Lignan Intake and Risk of Coronary Heart Disease.

Journal of the American College of Cardiology

Hu Y, Li Y, Sampson L, Wang M, Manson JE, Rimm E, Sun Q.
PMID: 34384548
J Am Coll Cardiol. 2021 Aug 17;78(7):666-678. doi: 10.1016/j.jacc.2021.05.049.

BACKGROUND: Evidence regarding lignan consumption in relation to coronary heart disease (CHD) risk remains limited and mixed.OBJECTIVES: The aim of this study was to prospectively examine associations between lignan intake and CHD risk in U.S. men and women.METHODS: We...

Cite
Hu Y, Li Y, Sampson L, et al. Lignan Intake and Risk of Coronary Heart Disease. J Am Coll Cardiol. 2021;78(7):666-678doi: 10.1016/j.jacc.2021.05.049.
Hu, Y., Li, Y., Sampson, L., Wang, M., Manson, J. E., Rimm, E., & Sun, Q. (2021). Lignan Intake and Risk of Coronary Heart Disease. Journal of the American College of Cardiology, 78(7), 666-678. https://doi.org/10.1016/j.jacc.2021.05.049
Hu, Yang, et al. "Lignan Intake and Risk of Coronary Heart Disease." Journal of the American College of Cardiology vol. 78,7 (2021): 666-678. doi: https://doi.org/10.1016/j.jacc.2021.05.049
Hu Y, Li Y, Sampson L, Wang M, Manson JE, Rimm E, Sun Q. Lignan Intake and Risk of Coronary Heart Disease. J Am Coll Cardiol. 2021 Aug 17;78(7):666-678. doi: 10.1016/j.jacc.2021.05.049. PMID: 34384548; PMCID: PMC8432598.
Copy Download .nbib Format: NLM
Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.

NPJ precision oncology

Ogino S, Jhun I, Mata DA, Soong TR, Hamada T, Liu L, Nishihara R, Giannakis M, Cao Y, Manson JE, Nowak JA, Chan AT.
PMID: 29552640
NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0042-x. Epub 2017 Dec 06.

Precision medicine has a goal of customizing disease prevention and treatment strategies. Under the precision medicine paradigm, each patient has unique pathologic processes resulting from cellular genomic, epigenomic, proteomic, and metabolomic alterations, which are influenced by pharmacological, environmental, microbial,...

Cite
Ogino S, Jhun I, Mata DA, et al. Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. NPJ Precis Oncol. 2017;1doi: 10.1038/s41698-017-0042-x.
Ogino, S., Jhun, I., Mata, D. A., Soong, T. R., Hamada, T., Liu, L., Nishihara, R., Giannakis, M., Cao, Y., Manson, J. E., Nowak, J. A., & Chan, A. T. (2017). Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. NPJ precision oncology, 1. https://doi.org/10.1038/s41698-017-0042-x
Ogino, Shuji, et al. "Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology." NPJ precision oncology vol. 1 (2017). doi: https://doi.org/10.1038/s41698-017-0042-x
Ogino S, Jhun I, Mata DA, Soong TR, Hamada T, Liu L, Nishihara R, Giannakis M, Cao Y, Manson JE, Nowak JA, Chan AT. Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology. NPJ Precis Oncol. 2017;1. doi: 10.1038/s41698-017-0042-x. Epub 2017 Dec 06. PMID: 29552640; PMCID: PMC5856171.
Copy Download .nbib Format: NLM
Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Circulation

Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM.
PMID: 34612056
Circulation. 2021 Dec 21;144(25):1981-1990. doi: 10.1161/CIRCULATIONAHA.121.055654. Epub 2021 Oct 06.

BACKGROUND: Some, but not all, large-scale randomized controlled trials (RCTs) investigating the effects of marine ɷ-3 fatty acids supplementation on cardiovascular outcomes have reported increased risks of atrial fibrillation (AF). The potential reasons for disparate findings may be dose-related.METHODS:...

Cite
Gencer B, Djousse L, Al-Ramady OT, et al. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021;144(25):1981-1990doi: 10.1161/CIRCULATIONAHA.121.055654.
Gencer, B., Djousse, L., Al-Ramady, O. T., Cook, N. R., Manson, J. E., & Albert, C. M. (2021). Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation, 144(25), 1981-1990. https://doi.org/10.1161/CIRCULATIONAHA.121.055654
Gencer, Baris, et al. "Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis." Circulation vol. 144,25 (2021): 1981-1990. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.055654
Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021 Dec 21;144(25):1981-1990. doi: 10.1161/CIRCULATIONAHA.121.055654. Epub 2021 Oct 06. PMID: 34612056.
Copy Download .nbib Format: NLM
The VITamin D and OmegA-3 TriaL (VITAL): Do Results Differ by Sex or Race/Ethnicity?.

American journal of lifestyle medicine

Bassuk SS, Chandler PD, Buring JE, Manson JE.
PMID: 34366734
Am J Lifestyle Med. 2020 Dec 24;15(4):372-391. doi: 10.1177/1559827620972035. eCollection 2021.

Whether vitamin D or marine omega-3 (n-3) fatty acid supplementation reduces risk of cancer or cardiovascular disease (CVD) in general populations at usual risk for these outcomes is relatively unexplored in randomized trials. The primary goal of the

Cite
Bassuk SS, Chandler PD, Buring JE, et al. The VITamin D and OmegA-3 TriaL (VITAL): Do Results Differ by Sex or Race/Ethnicity?. Am J Lifestyle Med. 2020;15(4):372-391doi: 10.1177/1559827620972035.
Bassuk, S. S., Chandler, P. D., Buring, J. E., Manson, J. E. (2021). The VITamin D and OmegA-3 TriaL (VITAL): Do Results Differ by Sex or Race/Ethnicity?. American journal of lifestyle medicine, 15(4), 372-391. https://doi.org/10.1177/1559827620972035
Bassuk, Shari S, et al. "The VITamin D and OmegA-3 TriaL (VITAL): Do Results Differ by Sex or Race/Ethnicity?." American journal of lifestyle medicine vol. 15,4 (2021): 372-391. doi: https://doi.org/10.1177/1559827620972035
Bassuk SS, Chandler PD, Buring JE, Manson JE. The VITamin D and OmegA-3 TriaL (VITAL): Do Results Differ by Sex or Race/Ethnicity?. Am J Lifestyle Med. 2020 Dec 24;15(4):372-391. doi: 10.1177/1559827620972035. eCollection 2021. PMID: 34366734; PMCID: PMC8299924.
Copy Download .nbib Format: NLM
Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial.

International journal of obesity (2005)

Heianza Y, Zhou T, He H, DiDonato JA, Bray GA, Sacks FM, Qi L.
PMID: 34426648
Int J Obes (Lond). 2021 Dec;45(12):2600-2607. doi: 10.1038/s41366-021-00939-7. Epub 2021 Aug 23.

BACKGROUND/OBJECTIVES: Alterations in gut microbiota have been linked to obesity and impaired lipid metabolism. Lipoproteins are heterogeneous, and lipoprotein subspecies containing apolipoprotein C-III (apoCIII) have adverse associations with obesity and related cardiometabolic abnormalities. We investigated associations of weight-loss diet-induced...

Cite
Heianza Y, Zhou T, He H, et al. Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial. Int J Obes (Lond). 2021;45(12):2600-2607doi: 10.1038/s41366-021-00939-7.
Heianza, Y., Zhou, T., He, H., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2021). Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial. International journal of obesity (2005), 45(12), 2600-2607. https://doi.org/10.1038/s41366-021-00939-7
Heianza, Yoriko, et al. "Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial." International journal of obesity (2005) vol. 45,12 (2021): 2600-2607. doi: https://doi.org/10.1038/s41366-021-00939-7
Heianza Y, Zhou T, He H, DiDonato JA, Bray GA, Sacks FM, Qi L. Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial. Int J Obes (Lond). 2021 Dec;45(12):2600-2607. doi: 10.1038/s41366-021-00939-7. Epub 2021 Aug 23. PMID: 34426648; PMCID: PMC8608703.
Copy Download .nbib Format: NLM
Prolactin and Risk of Epithelial Ovarian Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS.
PMID: 34244157
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08.

BACKGROUND: Prolactin is synthesized in the ovaries and may play a role in ovarian cancer etiology. One prior prospective study observed a suggestive positive association between prolactin levels and risk of ovarian cancer.METHODS: We conducted a pooled case-control study...

Cite
Hathaway CA, Rice MS, Townsend MK, et al. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(9):1652-1659doi: 10.1158/1055-9965.EPI-21-0139.
Hathaway, C. A., Rice, M. S., Townsend, M. K., Hankinson, S. E., Arslan, A. A., Buring, J. E., Hallmans, G., Idahl, A., Kubzansky, L. D., Lee, I. M., Lundin, E. A., Sluss, P. M., Zeleniuch-Jacquotte, A., & Tworoger, S. S. (2021). Prolactin and Risk of Epithelial Ovarian Cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(9), 1652-1659. https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway, Cassandra A, et al. "Prolactin and Risk of Epithelial Ovarian Cancer." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,9 (2021): 1652-1659. doi: https://doi.org/10.1158/1055-9965.EPI-21-0139
Hathaway CA, Rice MS, Townsend MK, Hankinson SE, Arslan AA, Buring JE, Hallmans G, Idahl A, Kubzansky LD, Lee IM, Lundin EA, Sluss PM, Zeleniuch-Jacquotte A, Tworoger SS. Prolactin and Risk of Epithelial Ovarian Cancer. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1652-1659. doi: 10.1158/1055-9965.EPI-21-0139. Epub 2021 Jul 08. PMID: 34244157; PMCID: PMC8419083.
Copy Download .nbib Format: NLM
Associations between fruit juice and milk consumption and change in BMI in a large prospective cohort of U.S. adolescents and preadolescents.

Pediatric obesity

Sakaki JR, Li J, Gao S, Ha K, Tamimi RM, Chavarro JE, Chen MH, Sun Q, Hart JE, Chun OK.
PMID: 33648027
Pediatr Obes. 2021 Sep;16(9):e12781. doi: 10.1111/ijpo.12781. Epub 2021 Mar 01.

BACKGROUND: There are concerns that fruit juice and milk contribute to childhood obesity.OBJECTIVE: Determine the relationship between fruit juice and milk intakes and body mass index (BMI) change among preadolescents/adolescents.METHODS: Participants aged 9 to 16 years old from the...

Cite
Sakaki JR, Li J, Gao S, et al. Associations between fruit juice and milk consumption and change in BMI in a large prospective cohort of U.S. adolescents and preadolescents. Pediatr Obes. 2021;16(9):e12781doi: 10.1111/ijpo.12781.
Sakaki, J. R., Li, J., Gao, S., Ha, K., Tamimi, R. M., Chavarro, J. E., Chen, M. H., Sun, Q., Hart, J. E., & Chun, O. K. (2021). Associations between fruit juice and milk consumption and change in BMI in a large prospective cohort of U.S. adolescents and preadolescents. Pediatric obesity, 16(9), e12781. https://doi.org/10.1111/ijpo.12781
Sakaki, Junichi R, et al. "Associations between fruit juice and milk consumption and change in BMI in a large prospective cohort of U.S. adolescents and preadolescents." Pediatric obesity vol. 16,9 (2021): e12781. doi: https://doi.org/10.1111/ijpo.12781
Sakaki JR, Li J, Gao S, Ha K, Tamimi RM, Chavarro JE, Chen MH, Sun Q, Hart JE, Chun OK. Associations between fruit juice and milk consumption and change in BMI in a large prospective cohort of U.S. adolescents and preadolescents. Pediatr Obes. 2021 Sep;16(9):e12781. doi: 10.1111/ijpo.12781. Epub 2021 Mar 01. PMID: 33648027; PMCID: PMC8355032.
Copy Download .nbib Format: NLM
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial.

Scientific reports

Kang JH, Vyas CM, Okereke OI, Ogata S, Albert M, Lee IM, D'Agostino D, Buring JE, Cook NR, Grodstein F, Manson JE.
PMID: 34853363
Sci Rep. 2021 Dec 01;11(1):23253. doi: 10.1038/s41598-021-02485-8.

Low vitamin D levels have been associated with cognitive decline; however, few randomized trials have been conducted. In a trial, we evaluated vitamin D3 supplementation on cognitive decline. We included participants aged 60+ years (mean[SD] = 70.9[5.8] years) free...

Cite
Kang JH, Vyas CM, Okereke OI, et al. Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. Sci Rep. 2021;11(1):23253doi: 10.1038/s41598-021-02485-8.
Kang, J. H., Vyas, C. M., Okereke, O. I., Ogata, S., Albert, M., Lee, I. M., D'Agostino, D., Buring, J. E., Cook, N. R., Grodstein, F., & Manson, J. E. (2021). Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. Scientific reports, 11(1), 23253. https://doi.org/10.1038/s41598-021-02485-8
Kang, Jae H, et al. "Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial." Scientific reports vol. 11,1 (2021): 23253. doi: https://doi.org/10.1038/s41598-021-02485-8
Kang JH, Vyas CM, Okereke OI, Ogata S, Albert M, Lee IM, D'Agostino D, Buring JE, Cook NR, Grodstein F, Manson JE. Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. Sci Rep. 2021 Dec 01;11(1):23253. doi: 10.1038/s41598-021-02485-8. PMID: 34853363; PMCID: PMC8636504.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 26 entries